International Drug & Explosives Detection Company IDenta Corp. Announces Orders Since January 1, 2012

JERUSALEM, Feb. 24, 2012 /PRNewswire/ -- IDenta Corp. (OTC: IDTA) CEO Yaacov Shoham today announced the following sales:

In the first (almost) two months of 2012, we have already received orders totaling $180.750 usd.

Orders were from:

France - 22850 usd

India - 10200 usd + 17000 usd

Argentina- 25000 usd

Israel - 15900 usd

Germany- 500 usd + 1300 usd

Portugal60000 usd

USA- 2500 usd

Ghana25500 usd

The orders for this almost two months period represent 90% of the entire orders for 2011 (in only almost two months).

"This is only the beginning, because we are expecting many more orders from other countries including the USA in the near future."

IDenta's entire product line may be found at www.Identa-corp.com, www.drugsdetector.com and www.Identa.biz.

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.drugsdetector.com, www.identa.biz, www.identa-corp.com.

Contact:

Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
fpi@drugsdetector.com
http://www.identa.biz

CONTACT: mailto:fpi@drugsdetector.com

SOURCE IDenta Corp.



RELATED LINKS
http://www.Identa-corp.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.